Haino Arisa, Ishikawa Tatsuya, Seki Mineaki, Nashimoto Masayuki
Research Institute for Healthy Living, Niigata University of Pharmacy and Applied Life Sciences.
Research Institute for Healthy Living, Niigata University of Pharmacy and Applied Life Sciences;
J Vis Exp. 2016 Jun 2(112):53879. doi: 10.3791/53879.
TRUE gene silencing (termed after tRNase Z(L)-utilizing efficacious gene silencing) is one of the RNA-directed gene silencing technologies, which utilizes an artificial small guide RNA (sgRNA) to guide tRNA 3' processing endoribonuclease, tRNase Z(L), to recognize a target RNA. sgRNAs can be taken up by cells without any transfection reagents and can downregulate their target RNA levels and/or induce apoptosis in human cancer cells. We have screened an sgRNA library containing 156 heptamer-type sgRNAs for the effect on viability of human myeloma and leukemia cells, and found that 20 of them can efficiently induce apoptosis in at least one of the cancer cell lines. Here we present a protocol for screening of a heptamer-type sgRNA library for potential therapeutic drugs against blood cancers. The protocol includes how to construct the sgRNA library, how to assess the effect of each sgRNA on cell viability, and how to further evaluate the effective sgRNAs by flow cytometry. Around 2,000 hits would be expected to be obtained by screening the full-scale sgRNA library composed of 16,384 heptamers.
真正的基因沉默(以利用tRNase Z(L)的有效基因沉默命名)是一种RNA导向的基因沉默技术,它利用人工小向导RNA(sgRNA)引导tRNA 3'加工核糖核酸酶tRNase Z(L)识别靶RNA。sgRNAs无需任何转染试剂即可被细胞摄取,并可下调其靶RNA水平和/或诱导人癌细胞凋亡。我们筛选了一个包含156个七聚体型sgRNAs的文库,以研究其对人骨髓瘤和白血病细胞活力的影响,发现其中20个能在至少一种癌细胞系中有效诱导凋亡。在此,我们提供了一种筛选七聚体型sgRNA文库以寻找抗血癌潜在治疗药物的方案。该方案包括如何构建sgRNA文库、如何评估每个sgRNA对细胞活力的影响以及如何通过流式细胞术进一步评估有效的sgRNAs。通过筛选由16384个七聚体组成的全尺寸sgRNA文库,预计将获得约2000个有效命中结果。